Guillermo E Umpierrez Selected Research

Hyperglycemia

10/2022	Efficacy and Safety of Intensive Versus Nonintensive Supplemental Insulin With a Basal-Bolus Insulin Regimen in Hospitalized Patients With Type 2 Diabetes: A Randomized Clinical Study.
3/2022	A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.
1/2022	InsulinAPP application protocol for the inpatient management of type 2 diabetes on a hospitalist-managed ward: a retrospective study.
1/2022	Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline.
1/2022	Hypoglycemic and Hyperglycemic Crises Among U.S. Adults With Diabetes and End-stage Kidney Disease: Population-Based Study, 2013-2017.
3/2021	Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19.
1/2021	Clinical Trials of COVID-19 Therapies Should Account for Diabetes and Hyperglycemia.
1/2021	Glycemic variability and cardiovascular disease in patients with type 2 diabetes.
1/2021	Inpatient Glycemic Control With Sliding Scale Insulin in Noncritical Patients With Type 2 Diabetes: Who Can Slide?
1/2021	Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guillermo E Umpierrez Research Topics

Disease

72	Hyperglycemia 10/2022 - 03/2002
69	Type 2 Diabetes Mellitus (MODY) 10/2022 - 03/2006
64	Hypoglycemia (Reactive Hypoglycemia) 11/2022 - 09/2004
20	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022 - 11/2002
17	Critical Illness (Critically Ill) 11/2022 - 09/2007
15	Ketosis 01/2022 - 03/2004
15	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2021 - 04/2003
9	Insulin Resistance 06/2020 - 03/2006
8	Diabetes Mellitus 01/2020 - 07/2004
6	Obesity 01/2022 - 01/2013
6	COVID-19 03/2021 - 07/2020
5	Hypertension (High Blood Pressure) 01/2022 - 07/2007
5	Infections 03/2021 - 08/2004
5	Inflammation (Inflammations) 01/2019 - 07/2012
4	Chronic Renal Insufficiency 01/2022 - 10/2020
4	Prediabetic State (Prediabetes) 01/2022 - 01/2018
4	Body Weight (Weight, Body) 12/2021 - 03/2013
4	Wounds and Injuries (Trauma) 10/2021 - 01/2003
4	Acute Kidney Injury (Acute Renal Failure) 01/2017 - 04/2010
3	Renal Insufficiency (Renal Failure) 01/2022 - 10/2018
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2019
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 10/2021 - 01/2016
3	Weight Gain 01/2021 - 10/2018
3	Diabetes Complications 06/2020 - 01/2017
3	Acidosis 01/2020 - 01/2003
3	Wound Infection (Wound Infections) 04/2017 - 04/2010
2	Weight Loss (Weight Reduction) 01/2022 - 01/2021
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2020
2	Vomiting 01/2019 - 08/2014
2	Nausea 01/2019 - 08/2014
2	Major Depressive Disorder (Major Depressive Disorders) 01/2019 - 01/2016
2	Bacteremia 04/2017 - 02/2011
2	Pneumonia (Pneumonitis) 02/2011 - 04/2010
1	Overweight 01/2022
1	Disease Progression 01/2022

Drug/Important Bio-Agent (IBA)

91	Insulin (Novolin)FDA Link 11/2022 - 01/2003
61	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 03/2002
39	Blood Glucose (Blood Sugar)IBA 11/2022 - 03/2002
14	Insulin Glargine (Lantus)FDA Link 01/2022 - 07/2009
13	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 08/2004
10	Hemoglobins (Hemoglobin)IBA 01/2022 - 09/2012
10	Sitagliptin Phosphate (Januvia)FDA Link 01/2021 - 03/2013
9	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 01/2015
8	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 03/2013
6	IncretinsIBA 01/2019 - 07/2013
6	Nonesterified Fatty Acids (NEFA)IBA 08/2017 - 08/2004
4	LipidsIBA 01/2022 - 06/2012
4	Glucagon-Like Peptide-1 ReceptorIBA 01/2021 - 08/2014
4	C-Reactive ProteinIBA 01/2019 - 08/2004
3	SodiumIBA 01/2022 - 06/2016
3	Bicarbonates (Hydrogen Carbonate)IBA 01/2021 - 09/2004
3	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2020 - 06/2016
3	Dipeptidyl-Peptidase IV InhibitorsIBA 07/2020 - 01/2018
3	InsulinsIBA 06/2020 - 02/2009
3	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2019 - 09/2014
3	LinagliptinIBA 11/2019 - 01/2018
3	phospholipid emulsion soybean oil (Intralipid)IBA 03/2010 - 05/2007
3	CytokinesIBA 05/2008 - 03/2004
2	GlucocorticoidsIBA 01/2022 - 01/2021
2	KetonesIBA 01/2022 - 01/2003
2	Liraglutide FDA Link 01/2021 - 02/2016
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 11/2020 - 03/2015
2	Hormones (Hormone)IBA 10/2020 - 09/2014
2	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2020 - 08/2004
2	Growth Hormone (Somatotropin)IBA 10/2020 - 08/2004
2	CarbohydratesIBA 01/2020 - 02/2013
2	Pioglitazone (Actos)FDA Link 01/2020 - 03/2013
2	Allopurinol (Remid)FDA LinkGeneric 01/2020 - 01/2019
2	Uric Acid (Urate)IBA 01/2020 - 01/2019
2	lixisenatideIBA 11/2019 - 01/2017
2	Pharmaceutical PreparationsIBA 11/2019 - 03/2018
2	ThiazolidinedionesIBA 01/2018 - 03/2013
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 08/2017 - 04/2012
2	ElectrolytesIBA 03/2016 - 01/2003
2	Short-Acting InsulinIBA 04/2015 - 05/2008
2	dulaglutideIBA 03/2015 - 08/2014
2	2,4-thiazolidinedione (thiazolidinedione)IBA 03/2013 - 12/2009
2	LeptinIBA 05/2008 - 06/2003
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2004 - 03/2004
1	finerenoneIBA 01/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	insulin degludecIBA 01/2022

Therapy/Procedure

56	Therapeutics 01/2022 - 11/2002
42	Glycemic Control 11/2022 - 11/2005
27	Length of Stay 01/2021 - 12/2002
7	Critical Care (Surgical Intensive Care) 01/2022 - 09/2004
3	Enteral Nutrition (Feeding, Tube) 01/2022 - 04/2009
3	Drug Therapy (Chemotherapy) 06/2020 - 11/2010
3	Parenteral Nutrition 02/2013 - 04/2011
3	Intravenous Infusions 04/2010 - 09/2004
2	Surgical Amputation (Amputations) 01/2022 - 12/2020
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2021 - 01/2017
2	Renal Dialysis (Hemodialysis) 10/2020 - 01/2020
2	Injections 06/2020 - 03/2018
2	Artificial Respiration (Mechanical Ventilation) 01/2020 - 11/2005
2	Long-Term Care 01/2018 - 01/2015
2	Total Parenteral Nutrition 01/2014 - 04/2010
2	Pancreatectomy 11/2010 - 04/2010
2	Duration of Therapy 09/2004 - 08/2004
1	Investigational Therapies (Experimental Therapy) 03/2022